Abstract
The SARS-CoV-2 pandemic has had an unprecedented impact on multiple levels of society. Not only has the pandemic completely overwhelmed some health systems but it has also changed how scientific evidence is shared and increased the pace at which such evidence is published and consumed, by scientists, policymakers and the wider public. More significantly, the pandemic has created tremendous challenges for decision-makers, who have had to implement highly disruptive containment measures with very little empirical scientific evidence to support their decision-making process. Given this lack of data, predictive mathematical models have played an increasingly prominent role. In high-income countries, there is a long-standing history of established research groups advising policymakers, whereas a general lack of translational capacity has meant that mathematical models frequently remain inaccessible to policymakers in low-income and middle-income countries. Here, we describe a participatory approach to modelling that aims to circumvent this gap. Our approach involved the creation of an international group of infectious disease modellers and other public health experts, which culminated in the establishment of the COVID-19 Modelling (CoMo) Consortium. Here, we describe how the consortium was formed, the way it functions, the mathematical model used and, crucially, the high degree of engagement fostered between CoMo Consortium members and their respective local policymakers and ministries of health.
Funder
Bill and Melinda Gates Foundation
Li Ka Shing Foundation
Subject
Public Health, Environmental and Occupational Health,Health Policy
Reference56 articles.
1. COVID-19 Dashboard: Johns Hopkins University. Available: https://coronavirus.jhu.edu/map.html
2. The COVID-19 pandemic: diverse contexts; different epidemics—how and why?
3. Mathematical models as public troubles in COVID-19 infection control: following the numbers;Rhodes;Health Sociology Review,2020
4. Flaxman S . Report 13: estimating the number of infections and the impact of non-pharmaceutical interventions on COVID-19 in 11 European countries, 2020.
5. Effects of non-pharmaceutical interventions on COVID-19 cases, deaths, and demand for hospital services in the UK: a modelling study;Davies;Lancet Public Health,2020